Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
OBJECTIVE:To evaluate the effectiveness and toxicities in T4 nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT) combined with chemotherapy. METHODS:This is a retrospective analysis of 81 patients treated with intensity-modulated radiotherapy (IMRT). All the primary tumors w...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3946722?pdf=render |
id |
doaj-8c15f6b6540042268f40416a087842ae |
---|---|
record_format |
Article |
spelling |
doaj-8c15f6b6540042268f40416a087842ae2020-11-25T01:26:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e9136210.1371/journal.pone.0091362Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.Fang-Fang KongHongmei YingCheng-Run DuShuang HuangJun-Jun ZhouChao-Su HuChao-Su HuOBJECTIVE:To evaluate the effectiveness and toxicities in T4 nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT) combined with chemotherapy. METHODS:This is a retrospective analysis of 81 patients treated with intensity-modulated radiotherapy (IMRT). All the primary tumors were attributed to T4 stage according to the AJCC2010 staging system. And the distribution of disease by N stage was N0 in 13.6%, N1 in 30.9%, N2 in 37%, and N3 in 18.5%. Cisplatin-based chemotherapy was offered to all patients. Radiotherapy-related toxicities were graded according to the Acute and the Late Radiation Morbidity Scoring Criteria of the Radiation Therapy Oncology Group (RTOG) scoring criteria. Chemotherapy-related toxicities were graded by National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0. Prognostic factors were assessed by univariate analysis. RESULTS:With a median follow-up of 37 months, 12 patients experienced local regional failure and total distant metastasis occurred in 18 patients, representing the major mode of failure. Ten patients died. Among them, 70% died of distant metastasis. The 3-year actuarial rates of local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), overall survival (OS), and progression-free survival (PFS) were 83.8%, 97.4%, 81.3%, 90%, and 69.7%, respectively. Acute and late toxicities were mild or moderate. CONCLUSIONS:IMRT provides excellent local-regional control for T4 NPC. Distant metastasis remains the major cause of treatment failure. Further explorations of the sequence and regimen of systemic therapy are needed in the future.http://europepmc.org/articles/PMC3946722?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fang-Fang Kong Hongmei Ying Cheng-Run Du Shuang Huang Jun-Jun Zhou Chao-Su Hu Chao-Su Hu |
spellingShingle |
Fang-Fang Kong Hongmei Ying Cheng-Run Du Shuang Huang Jun-Jun Zhou Chao-Su Hu Chao-Su Hu Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma. PLoS ONE |
author_facet |
Fang-Fang Kong Hongmei Ying Cheng-Run Du Shuang Huang Jun-Jun Zhou Chao-Su Hu Chao-Su Hu |
author_sort |
Fang-Fang Kong |
title |
Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma. |
title_short |
Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma. |
title_full |
Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma. |
title_fullStr |
Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma. |
title_full_unstemmed |
Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma. |
title_sort |
effectiveness and toxicities of intensity-modulated radiation therapy for patients with t4 nasopharyngeal carcinoma. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
OBJECTIVE:To evaluate the effectiveness and toxicities in T4 nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT) combined with chemotherapy. METHODS:This is a retrospective analysis of 81 patients treated with intensity-modulated radiotherapy (IMRT). All the primary tumors were attributed to T4 stage according to the AJCC2010 staging system. And the distribution of disease by N stage was N0 in 13.6%, N1 in 30.9%, N2 in 37%, and N3 in 18.5%. Cisplatin-based chemotherapy was offered to all patients. Radiotherapy-related toxicities were graded according to the Acute and the Late Radiation Morbidity Scoring Criteria of the Radiation Therapy Oncology Group (RTOG) scoring criteria. Chemotherapy-related toxicities were graded by National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0. Prognostic factors were assessed by univariate analysis. RESULTS:With a median follow-up of 37 months, 12 patients experienced local regional failure and total distant metastasis occurred in 18 patients, representing the major mode of failure. Ten patients died. Among them, 70% died of distant metastasis. The 3-year actuarial rates of local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), overall survival (OS), and progression-free survival (PFS) were 83.8%, 97.4%, 81.3%, 90%, and 69.7%, respectively. Acute and late toxicities were mild or moderate. CONCLUSIONS:IMRT provides excellent local-regional control for T4 NPC. Distant metastasis remains the major cause of treatment failure. Further explorations of the sequence and regimen of systemic therapy are needed in the future. |
url |
http://europepmc.org/articles/PMC3946722?pdf=render |
work_keys_str_mv |
AT fangfangkong effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma AT hongmeiying effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma AT chengrundu effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma AT shuanghuang effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma AT junjunzhou effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma AT chaosuhu effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma AT chaosuhu effectivenessandtoxicitiesofintensitymodulatedradiationtherapyforpatientswitht4nasopharyngealcarcinoma |
_version_ |
1725107675200487424 |